Agentic Discovery
GhostA daily brief covering AI agents in biomedical and drug discovery, pairing short news items with 'why it matters' commentary on each. The sample issues cover OpenAI's acquisition of a drug-development agent startup, lab-designed binders and benchmark studies of agent reliability.